当前位置: X-MOL 学术J. Am. Acad. Dermatol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics
Journal of the American Academy of Dermatology ( IF 13.8 ) Pub Date : 2019-02-13 , DOI: 10.1016/j.jaad.2018.11.057
Alan Menter , Bruce E. Strober , Daniel H. Kaplan , Dario Kivelevitch , Elizabeth Farley Prater , Benjamin Stoff , April W. Armstrong , Cody Connor , Kelly M. Cordoro , Dawn M.R. Davis , Boni E. Elewski , Joel M. Gelfand , Kenneth B. Gordon , Alice B. Gottlieb , Arthur Kavanaugh , Matthew Kiselica , Neil J. Korman , Daniela Kroshinsky , Mark Lebwohl , Craig L. Leonardi , Jason Lichten , Henry W. Lim , Nehal N. Mehta , Amy S. Paller , Sylvia L. Parra , Arun L. Pathy , Reena N. Rupani , Michael Siegel , Emily B. Wong , Jashin J. Wu , Vidhya Hariharan , Craig A. Elmets

Psoriasis is a chronic, inflammatory multisystem disease that affects up to 3.2% of the US population. This guideline addresses important clinical questions that arise in psoriasis management and care, providing recommendations based on the available evidence. The treatment of psoriasis with biologic agents will be reviewed, emphasizing treatment recommendations and the role of the dermatologist in monitoring and educating patients regarding benefits as well as associated risks.



中文翻译:

AAD-NPF联合使用生物制剂治疗和治疗牛皮癣的护理指南

牛皮癣是一种慢性炎性多系统疾病,影响了多达3.2%的美国人口。该指南解决了牛皮癣管理和护理中出现的重要临床问题,并根据现有证据提供了建议。将对生物制剂对牛皮癣的治疗进行回顾,强调治疗建议以及皮肤科医生在监测和教育患者益处以及相关风险方面的作用。

更新日期:2019-02-13
down
wechat
bug